India caps trade margins on anti-cancer drugs at 30%

India has capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing prices by up to 70%, according to the Indian Pharmaceutical Alliance. Medical experts at AIIMS welcomed the move, calling it a step toward affordable cancer care, while stressing the need for effective implementation, quality assurance, and uninterrupted drug supply.